Hispidulin (4',5,7-trihydroxy-6-methoxyflavone) is a natural compound derived from traditional Chinese medicinal herbs, and it is known to have an anti-inflammatory effect. Here, we investigated the effect of
hispidulin on the
immunoglobulin E (
IgE)-mediated allergic responses in rat basophilic
leukemia (RBL)-2H3 mast cells. When RBL-2H3 cells were sensitized with anti-dinitrophenyl (anti-DNP)
IgE and subsequently stimulated with DNP-
human serum albumin (HSA),
histamine and β-
hexosaminidase were released from the cells by degranulation of activated mast cells. However, pretreatment with
hispidulin before the stimulation of
DNP-HSA markedly attenuated release of both in anti-DNP
IgE-sensitized cells. Furthermore, we investigated whether
hispidulin inhibits anti-DNP
IgE and
DNP-HSA-induced passive cutaneous anaphylaxis (PCA), as an animal model for Type I
allergies.
Hispidulin markedly decreased the PCA reaction and allergic
edema of ears in mice. In addition, activated RBL-2H3 cells induced the expression of inflammatory
cytokines (
tumor necrosis factor-α and
interleukin-4), which are critical for the pathogenesis of allergic disease, through the activation of
c-Jun N-terminal kinase (JNK). Inhibition of JNK activation by
hispidulin treatment reduced the induction of
cytokine expression in the activated mast cells. Our results indicate that
hispidulin might be a possible therapeutic candidate for allergic inflammatory diseases through the suppression of degranulation and inflammatory
cytokines expression.